PCC Rokita SA (WSE:PCR)

Market Cap	1.35B -7.9%
Revenue (ttm)	1.80B -7.5%
Net Income	61.48M -57.0%
EPS	3.09 -57.1%
Shares Out	20.26M
PE Ratio	21.52
Forward PE	11.61
Dividend	5.05 (7.59%)
Ex-Dividend Date	May 2, 2025

Volume	4,971
Average Volume	11,030
Open	66.50
Previous Close	66.50
Day's Range	66.50 - 68.00
52-Week Range	60.40 - 80.40
Beta	0.66
RSI	50.55
Earnings Date	May 20, 2026

About PCC Rokita

PCC Rokita SA designs, produces, and sells chemical products in Poland, Germany, the European Union, rest of Europe, the United States, Asia, and internationally. It operates through five segments: Polyurethanes, Chlorine Derivatives, Other Chemical Activities, Energy and Other Activities. The Polyurethanes segment produces polyols, polyurethane systems, and prepolymers; and include flexible foams, rigid foams, coatings, elastomers, adhesives, and impregnations. The Chlorine Derivatives segment produces chlorine, alkalis, sodium hydroxide, caus...

• Industry: Chemicals
• Sector: Materials
• Founded: 2002
• Employees: 1,370
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: PCR

Financial Performance

In 2025, PCC Rokita's revenue was 1.80 billion, a decrease of -7.50% compared to the previous year's 1.95 billion. Earnings were 61.48 million, a decrease of -57.02%.